Literature DB >> 8145902

The epileptic spectrum in the congenital bilateral perisylvian syndrome. CBPS Multicenter Collaborative Study.

R Kuzniecky1, F Andermann, R Guerrini.   

Abstract

We studied the frequency, clinical and EEG characteristics, and outcome of the epileptic syndrome in 31 patients with a congenital neurologic syndrome characterized by pseudobulbar palsy, cognitive deficits, and bilateral perisylvian polymicrogyria. Seizures were present in 27 of 31 patients (87%) and usually began between the ages of 4 and 12 years; they commonly consisted of atypical absence, atonic/tonic, and generalized tonic-clonic seizures. Partial attacks were present in 26%. EEG demonstrated generalized spike and wave abnormalities and, less frequently, multifocal discharges, predominantly in centro-parietal regions. Seizures were poorly controlled in 65%, with the remaining patients well controlled. Seven patients underwent callosotomy, which resulted in seizure improvement. This study indicates that the epileptic spectrum in this syndrome is broad but follows predictable patterns. Callosotomy is a valuable treatment strategy in those with intractable drop attacks.

Entities:  

Mesh:

Year:  1994        PMID: 8145902     DOI: 10.1212/wnl.44.3_part_1.379

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Voxel-based morphometry and intellectual assessment in patients with congenital bilateral perisylvian syndrome.

Authors:  Clarissa L Yasuda; Catarina A Guimarães; Marilisa M Guerreiro; Mirela Boscariol; Ecila P M Oliveira; Karine C Teixeira; André L F Costa; Guilherme C Beltramini; Fernando Cendes
Journal:  J Neurol       Date:  2014-04-30       Impact factor: 4.849

2.  Congenital unilateral perisylvian syndrome: radiological basis and clinical correlations.

Authors:  G Sébire; B Husson; A Dusser; Y Navelet; M Tardieu; P Landrieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

3.  Discordant clinical and neuroradiological features of congenital bilateral perisylvian syndrome in monozygotic female twins.

Authors:  C Lenti; F Triulzi
Journal:  Ital J Neurol Sci       Date:  1996-08

4.  Language abilities and gestural communication in a girl with bilateral perisylvian syndrome: a clinical and rehabilitative follow-up.

Authors:  Bruna Molteni; Daniela Sarti; Gloria Airaghi; Chiara Falcone; Giulia Mantegazza; Giovanni Baranello; Federica Riva; Veronica Saletti; Nicoletta Paruta; Daria Riva
Journal:  Neurol Sci       Date:  2010-06-02       Impact factor: 3.307

5.  Ictal technetium-99 m ethyl cysteinate dimer single-photon emission tomographic findings in epileptic patients with polymicrogyria syndromes: a subtraction of ictal-interictal SPECT coregistered to MRI study.

Authors:  Lauro Wichert-Ana; Paulo Mazzoncini de Azevedo-Marques; Lucas Ferrari Oliveira; Regina Maria França Fernandes; Tonicarlo Rodrigues Velasco; Antonio Carlos Santos; David Araújo; Mery Kato; Marino Muxfeldt Bianchin; Américo Ceiki Sakamoto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-21       Impact factor: 9.236

6.  Callosotomy for severe epilepsies with generalized seizures: outcome and prognostic factors.

Authors:  G F Rossi; G Colicchio; E Marchese; A Pompucci
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

7.  Polymicrogyria-associated epilepsy: a multicenter phenotypic study from the Epilepsy Phenome/Genome Project.

Authors:  Catherine Shain; Sriram Ramgopal; Zianka Fallil; Isha Parulkar; Richard Alongi; Robert Knowlton; Annapurna Poduri
Journal:  Epilepsia       Date:  2013-06-10       Impact factor: 5.864

8.  Congenital bilateral perislyvian syndrome: case report and review of literature.

Authors:  Anand K Gowda; Ranoji Shivaji Mane; Ashok Kumar
Journal:  J Clin Neonatol       Date:  2013-10

Review 9.  Malformations of cortical development and epilepsy.

Authors:  Richard J Leventer; Renzo Guerrini; William B Dobyns
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.